Age Restriction to be Updated in the TMPPM for Hympavzi
Date: August 21, 2026
Attention: All Providers
Effective date: October 1, 2026
Call to action: Texas Children's Health Plan (TCHP) would like to inform providers that on October 1, 2026, the Texas Medicaid & Healthcare Partnership (TMHP) will update the Texas Medicaid Provider Procedures Manual (TMPPM), Outpatient Drug Services Handbook, section 6.61.6, “Hympavzi (Marstacimab-hncq),” to align the age restriction with the restriction on the U.S. Food and Drug Administration (FDA) label.
The age for Hympavzi (marstacimab-hncq) (procedure code J7172) will be updated from 12 years of age or older to 6 years of age or older.
Next step for providers: Providers should share this information with their staff.
If you have any questions, please email Provider Relations at providerrelations@texaschildrens.org.
For access to all provider alerts: www.texaschildrenshealthplan.org/provideralerts.